Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 18-Jun-24 5:00 PM View:  | Piccina Cintia Chief Commercial Officer | Adaptimmune Therapeutics plc (ADAP) | 18-Jun-24 | Sale | 24,531 | $0.93 | $22,813.80 | (39%) 62.82K to 38.29K | |
| 17-Jan-24 5:31 PM View: | Rawcliffe Adrian Chief Executive Officer Director | Adaptimmune Therapeutics plc (ADAP) | 17-Jan-24 | Sale | 30,080 | $0.67 | $20,243.80 | (40%) 74.93K to 44.85K | |
| 17-Jan-24 5:30 PM View: | Lunger John Chief Patient Supply Officer | Adaptimmune Therapeutics plc (ADAP) | 17-Jan-24 | Sale | 18,114 | $0.67 | $12,190.70 | (49%) 37.13K to 19.02K | |
| 17-Jan-24 5:31 PM View: | Norry Elliot Chief Medical Officer | Adaptimmune Therapeutics plc (ADAP) | 17-Jan-24 | Sale | 18,276 | $0.67 | $12,299.70 | (49%) 37.53K to 19.26K | |
| 17-Jan-24 5:30 PM View: | Bertrand William C Jr Chief Operating Officer | Adaptimmune Therapeutics plc (ADAP) | 17-Jan-24 | Sale | 18,908 | $0.67 | $12,725.10 | (48%) 39.11K to 20.2K | |
| 17-Jan-24 5:31 PM View: | Norry Elliot Chief Medical Officer | Adaptimmune Therapeutics plc (ADAP) | 16-Jan-24 | Sale | 2,287 | $0.79 | $1,806.73 | (40%) 5.65K to 3.36K | |
| 17-Jan-24 5:30 PM View: | Bertrand William C Jr Chief Operating Officer | Adaptimmune Therapeutics plc (ADAP) | 16-Jan-24 | Sale | 4,681 | $0.79 | $3,697.99 | (40%) 11.7K to 7.02K | |
| 17-Jan-24 5:31 PM View: | Rawcliffe Adrian Chief Executive Officer Director | Adaptimmune Therapeutics plc (ADAP) | 16-Jan-24 | Sale | 9,304 | $0.79 | $7,350.16 | (40%) 23.41K to 14.1K | |
| 17-Jan-24 5:30 PM View: | Lunger John Chief Patient Supply Officer | Adaptimmune Therapeutics plc (ADAP) | 16-Jan-24 | Sale | 4,681 | $0.79 | $3,697.99 | (40%) 11.7K to 7.02K | |
| 12-Jan-24 5:00 PM View: | Bertrand William C Jr Chief Operating Officer | Adaptimmune Therapeutics plc (ADAP) | 12-Jan-24 | Sale | 5,220 | $0.85 | $4,458.40 | (40%) 13.09K to 7.87K | |
| 12-Jan-24 5:00 PM View: | Rawcliffe Adrian Chief Executive Officer Director | Adaptimmune Therapeutics plc (ADAP) | 12-Jan-24 | Sale | 17,257 | $0.85 | $14,739.20 | (40%) 43.65K to 26.39K | |
| 12-Jan-24 5:00 PM View: | Lunger John Chief Patient Supply Officer | Adaptimmune Therapeutics plc (ADAP) | 12-Jan-24 | Sale | 5,220 | $0.85 | $4,458.40 | (40%) 13.09K to 7.87K | |
| 12-Jan-24 5:00 PM View: | Norry Elliot Chief Medical Officer | Adaptimmune Therapeutics plc (ADAP) | 12-Jan-24 | Sale | 7,799 | $0.85 | $6,661.13 | (40%) 19.64K to 11.84K | |
| 12-Jan-24 5:00 PM View: | Rawcliffe Adrian Chief Executive Officer Director | Adaptimmune Therapeutics plc (ADAP) | 11-Jan-24 | Sale | 11,945 | $0.84 | $9,994.38 | (39%) 30.34K to 18.39K | |
| 12-Jan-24 5:00 PM View: | Lunger John Chief Patient Supply Officer | Adaptimmune Therapeutics plc (ADAP) | 11-Jan-24 | Sale | 4,009 | $0.84 | $3,354.33 | (40%) 10.11K to 6.1K | |
| 12-Jan-24 5:00 PM View: | Norry Elliot Chief Medical Officer | Adaptimmune Therapeutics plc (ADAP) | 11-Jan-24 | Sale | 4,009 | $0.84 | $3,354.33 | (40%) 10.11K to 6.1K | |
| 12-Jan-24 5:00 PM View: | Bertrand William C Jr Chief Operating Officer | Adaptimmune Therapeutics plc (ADAP) | 11-Jan-24 | Sale | 4,009 | $0.84 | $3,354.33 | (40%) 10.11K to 6.1K | |
| 01-Sep-23 7:00 PM View: | Rawcliffe Adrian Chief Executive Officer Director | Adaptimmune Therapeutics plc (ADAP) | 01-Sep-23 | Sale | 2,403 | $0.78 | $1,874.34 | (41%) 5.85K to 3.45K | |
| 01-Aug-23 5:00 PM View: | Lunger John Chief Patient Supply Officer | Adaptimmune Therapeutics plc (ADAP) | 01-Aug-23 | Sale | 3,096 | $0.91 | $2,803.74 | (40%) 7.81K to 4.72K | |
| 10-Jul-23 5:01 PM View: | Menzel Garry E Director | Adaptimmune Therapeutics plc (ADAP) | 10-Jul-23 | Sale | 47,702 | $0.91 | $43,447.00 | (39%) 122.76K to 75.06K | |
| 27-Jun-23 9:15 PM View: | Rawcliffe Adrian Chief Executive Officer Director | Adaptimmune Therapeutics plc (ADAP) | 27-Jun-23 | Sale | 2,333 | $0.92 | $2,146.36 | (40%) 5.85K to 3.52K | |
| 01-Jun-23 4:59 PM View: | Menzel Garry E Director | Adaptimmune Therapeutics plc (ADAP) | 01-Jun-23 | Grant | 209,931 | -- | -- | 52% 401.29K to 611.22K | |
| 01-Jun-23 4:59 PM View: | Menzel Garry E Director | Adaptimmune Therapeutics plc (ADAP) | 01-Jun-23 | Grant | 401,293 | -- | -- | 100% 0 to 401.29K | |
| 31-Jan-23 9:02 PM View: | Piccina Cintia Chief Commercial Officer | Adaptimmune Therapeutics plc (ADAP) | 31-Jan-23 | Sale | 11,890 | $1.87 | $22,229.50 | (38%) 31.43K to 19.54K | |
| 17-Jan-23 9:15 PM View: | Rawcliffe Adrian Chief Executive Officer Director | Adaptimmune Therapeutics plc (ADAP) | 17-Jan-23 | Sale | 10,057 | $1.86 | $18,685.90 | (43%) 23.41K to 13.35K | |
| 17-Jan-23 9:16 PM View: | Norry Elliot Chief Medical Officer | Adaptimmune Therapeutics plc (ADAP) | 17-Jan-23 | Sale | 2,159 | $1.86 | $4,011.42 | (38%) 5.65K to 3.49K | |
| 17-Jan-23 9:17 PM View: | Lunger John Chief Patient Supply Officer | Adaptimmune Therapeutics plc (ADAP) | 17-Jan-23 | Sale | 4,440 | $1.86 | $8,249.52 | (38%) 11.7K to 7.26K | |
| 17-Jan-23 9:17 PM View: | Bertrand William C Jr Chief Operating Officer | Adaptimmune Therapeutics plc (ADAP) | 17-Jan-23 | Sale | 4,440 | $1.86 | $8,249.52 | (38%) 11.7K to 7.26K | |
| 12-Jan-23 9:02 PM View: | Lunger John Chief Patient Supply Officer | Adaptimmune Therapeutics plc (ADAP) | 12-Jan-23 | Sale | 4,973 | $1.71 | $8,483.94 | (38%) 13.09K to 8.12K | |
| 12-Jan-23 9:03 PM View: | Bertrand William C Jr Chief Operating Officer | Adaptimmune Therapeutics plc (ADAP) | 12-Jan-23 | Sale | 4,973 | $1.71 | $8,483.94 | (38%) 13.09K to 8.12K | |
| 12-Jan-23 9:00 PM View: | Rawcliffe Adrian Chief Executive Officer Director | Adaptimmune Therapeutics plc (ADAP) | 12-Jan-23 | Sale | 18,763 | $1.71 | $32,009.70 | (43%) 43.65K to 24.88K | |
| 12-Jan-23 9:01 PM View: | Norry Elliot Chief Medical Officer | Adaptimmune Therapeutics plc (ADAP) | 12-Jan-23 | Sale | 7,449 | $1.71 | $12,708.00 | (38%) 19.64K to 12.19K | |
| 12-Jan-23 9:00 PM View: | Rawcliffe Adrian Chief Executive Officer Director | Adaptimmune Therapeutics plc (ADAP) | 11-Jan-23 | Sale | 13,042 | $1.75 | $22,781.80 | (43%) 30.34K to 17.3K | |
| 12-Jan-23 9:01 PM View: | Norry Elliot Chief Medical Officer | Adaptimmune Therapeutics plc (ADAP) | 11-Jan-23 | Sale | 3,843 | $1.75 | $6,712.95 | (38%) 10.11K to 6.27K | |
| 12-Jan-23 9:02 PM View: | Lunger John Chief Patient Supply Officer | Adaptimmune Therapeutics plc (ADAP) | 11-Jan-23 | Sale | 3,843 | $1.75 | $6,712.95 | (38%) 10.11K to 6.27K | |
| 12-Jan-23 9:03 PM View: | Bertrand William C Jr Chief Operating Officer | Adaptimmune Therapeutics plc (ADAP) | 11-Jan-23 | Sale | 3,843 | $1.75 | $6,712.95 | (38%) 10.11K to 6.27K | |
| 04-Jan-23 9:00 PM View: | Rawcliffe Adrian Chief Executive Officer Director | Adaptimmune Therapeutics plc (ADAP) | 04-Jan-23 | Sale | 5,073 | $1.69 | $8,593.66 | (43%) 11.7K to 6.63K | |
| 04-Jan-23 9:01 PM View: | Norry Elliot Chief Medical Officer | Adaptimmune Therapeutics plc (ADAP) | 04-Jan-23 | Sale | 876 | $1.69 | $1,483.94 | (39%) 2.24K to 1.36K | |
| 04-Jan-23 9:01 PM View: | Lunger John Chief Patient Supply Officer | Adaptimmune Therapeutics plc (ADAP) | 04-Jan-23 | Sale | 1,100 | $1.69 | $1,863.40 | (39%) 2.83K to 1.73K | |
| 04-Jan-23 9:02 PM View: | Bertrand William C Jr Chief Operating Officer | Adaptimmune Therapeutics plc (ADAP) | 04-Jan-23 | Sale | 3,584 | $1.69 | $6,071.30 | (38%) 9.37K to 5.78K | |
| 01-Sep-22 9:00 PM View: | Rawcliffe Adrian Chief Executive Officer Director | Adaptimmune Therapeutics plc (ADAP) | 01-Sep-22 | Sale | 2,536 | $1.97 | $4,993.13 | (43%) 5.85K to 3.32K | |
| 01-Aug-22 9:01 PM View: | Lunger John Chief Patient Supply Officer | Adaptimmune Therapeutics plc (ADAP) | 01-Aug-22 | Sale | 2,983 | $1.77 | $5,290.35 | (38%) 7.81K to 4.83K | |
| 01-Aug-22 9:00 PM View: | Piccina Cintia Chief Commercial Officer | Adaptimmune Therapeutics plc (ADAP) | 01-Aug-22 | Sale | 21,040 | $1.77 | $37,314.40 | (38%) 55.86K to 34.82K | |
| 05-Jul-22 9:00 PM View: | Lunger John Chief Patient Supply Officer | Adaptimmune Therapeutics plc (ADAP) | 05-Jul-22 | Sale | 1,973 | $1.68 | $3,310.89 | (39%) 5.08K to 3.1K | |
| 27-Jun-22 9:01 PM View: | Rawcliffe Adrian Chief Executive Officer Director | Adaptimmune Therapeutics plc (ADAP) | 27-Jun-22 | Sale | 2,562 | $1.63 | $4,176.06 | (44%) 5.85K to 3.29K | |
| 23-May-22 9:00 PM View: | Wood Gavin Chief Financial Officer | Adaptimmune Therapeutics plc (ADAP) | 20-May-22 | Private Purchase | 39,000 | $0.29 | $11,325.60 | 68% 57.0K to 96.0K | |
| 18-Jan-22 9:04 PM View: | Bertrand William C Jr Chief Operating Officer | Adaptimmune Therapeutics plc (ADAP) | 18-Jan-22 | Market Sale | 4,368 | $3.19 | $13,941.80 | (37%) 11.7K to 7.34K | (9%) |
| 18-Jan-22 9:03 PM View: | Lunger John Chief Patient Supply Officer | Adaptimmune Therapeutics plc (ADAP) | 18-Jan-22 | Market Sale | 4,368 | $3.19 | $13,941.80 | (37%) 11.7K to 7.34K | (9%) |
| 18-Jan-22 9:02 PM View: | Norry Elliot Chief Medical Officer | Adaptimmune Therapeutics plc (ADAP) | 18-Jan-22 | Market Sale | 2,121 | $3.19 | $6,769.81 | (38%) 5.65K to 3.53K | (9%) |
| 18-Jan-22 9:00 PM View: | Rawcliffe Adrian Chief Executive Officer Director | Adaptimmune Therapeutics plc (ADAP) | 18-Jan-22 | Market Sale | 11,096 | $3.19 | $35,416.20 | (47%) 23.41K to 12.31K | (9%) |
